• Encouraging high-level results for first-in-human trial of HNSA-5487 • Well attended Hansa-sponsored symposium at ESOT focusing on first patient experiences • Dr. Hitto Kaufmann appointed new CSO LUND, Sweden, Oct. 26, 2023 /PRNewswire/ — Hansa Biopharma, the pioneer in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.